IBA to install a proton therapy solution in Charleroi, Belgium, and Dosimetry update
21 Décembre 2018 - 7:00AM
IBA to install a proton therapy solution in Charleroi, Belgium, and
Dosimetry update
IBA receives purchase order to install
its Proteus®ONE compact proton therapy solution in
CharleroiStrategic review of Dosimetry division
ongoing
Louvain-La-Neuve, Belgium, 21 December
2018 - IBA (Ion Beam Applications S.A., EURONEXT), the
world’s leading provider of proton therapy solutions for the
treatment of cancer, today announces it has received a formal order
from four leading universities – the Free University of Brussels
(L’Université Libre de Bruxelles - ULB), the University of Liège
(ULiège), the University of Mons (UMons), the University of Namur
(UNamur) – to install a Proteus®ONE* compact proton therapy
solution in Charleroi, Wallonia Region, Belgium. A full downpayment
for the project is expected to be received by IBA in the coming
days following confirmation from the Walloon Government on Thursday
13 December 2018 that it has secured its financing for this proton
therapy project.
The value of the contract is estimated between
EUR 25 million and EUR 30 million. It includes the equipment and
the service contract, as well as research programs in
collaboration with the four universities. The Catholic University
of Louvain (UCLouvain) will also participate in complementary
research programs in collaboration with the four founding
universities. IBA was selected as the preferred vendor for this
project in February 2017 following a comprehensive European public
tender process.
This will be IBA’s 25th installation of its
compact single-room proton therapy solution and will be the second
proton therapy center in Belgium. This is the seventh Proteus®ONE
contract signed this year by IBA. Three of these contracts are
still awaiting financing and one is a term sheet for which IBA has
already received the downpayment.
Dosimetry strategic review
Following the announcement of the strategic evaluation of the
Dosimetry division, IBA can confirm that the process has not yet
led to a conclusion and discussions continue on several potential
outcomes. The Company will update the market on this strategic
review in due course.
***ENDS***
About Proteus®ONE
Proteus®ONE is the compact intensity modulated
proton therapy (IMPT) solution from IBA. It benefits from the
latest technologies developed with renowned clinical institutions.
Proteus®ONE is smaller, more affordable, easier to install and to
operate. It is ultimately easier to finance, making this advanced
radiation therapy modality available to more institutions and
patients worldwide.
* Proteus®ONE is the brand name of
Proteus®235
About IBA
IBA (Ion Beam Applications S.A.) is a global
medical technology company focused on bringing integrated and
innovative solutions for the diagnosis and treatment of cancer. The
company is the worldwide technology leader in the field of proton
therapy, considered to be the most advanced form of radiation
therapy available today. IBA’s proton therapy solutions are
flexible and adaptable, allowing customers to choose from universal
full-scale proton therapy centers as well as compact, single room
solutions. In addition, IBA also has a radiation dosimetry business
and develops particle accelerators for the medical world and
industry. Headquartered in Belgium and employing about 1,500 people
worldwide, IBA has installed systems across the world.
IBA is listed on the pan-European stock exchange
NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at:
www.iba-worldwide.com
For further information, please
contact:
IBA
Soumya
ChandramouliChief Financial Officer+32 10
475 890Investorrelations@iba-group.com
Thomas RaletVice-President
Corporate Communication+32 10 20 12
48communication@iba-group.com
For media and investor
enquiries:Consilium Strategic
CommunicationsAmber Fennell, Matthew Neal, Angela Gray+44
(0) 20 3709 5700IBA@consilium-comms.com
-
20181214-IBA_to_Install_Proton_Therapy_Center_in_Charleroi-and-Dosi-Update-EN
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024